Anna Måsbäck (Former)
1 – 10 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
(2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
- 2024
-
Mark
Tru-cut biopsy in gynecological cancer: adequacy, accuracy, safety and clinical applicability
(2024) 34th World Congress on Ultrasound in Obstetrics and Gynecology In Ultrasound in Obstetrics & Gynecology 64(S1). p.65-65
- Contribution to journal › Published meeting abstract
-
Mark
Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer
- Contribution to journal › Article
- 2023
-
Mark
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
- Contribution to journal › Article
- 2022
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
- Contribution to journal › Published meeting abstract
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
- Contribution to journal › Article
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
(2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
- 2021
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
- Contribution to journal › Article
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
